. Author manuscript; available in PMC: 2018 Jun 1.

Published in final edited form as: Neuromodulation. 2017 Mar 21;20(4):354–360. doi: 10.1111/ner.12584

Table 5.

Annual Cost Over 9-Year Period Post-SCS

Variable – Median[IQR] Mean (SD)	Commercial	Medicare	Medicaid	P-Value
Total Cost	2098.1 [0.0, 8919.6]	7158.1 [3160.4, 13916.6]	4045.6 [1146.9, 11533.9]	<0.0001*
Total Cost	6813.5 (12390.1)	11151.3 (20420.0)	8164.3 (10283.7)	<0.0001*
Pain Procedural Costs	0.0 [0.0, 100.9]	0.0 [0.0, 322.8]	0.0 [0.0, 133.9]	<0.0001*
Pain Procedural Costs	711.2 (2705.7)	640.8 (2089.8)	439.6 (1978.3)	<0.0001*
Pain Prescription Cost	552.1 [103.3, 1875.2]	341.4 [54.4, 1188.4]	2.1 [0.0, 23.7]	<0.0001*
Pain Prescription Cost	1390.1 (1995.6)	970.9 (1524.0)	342.2 (1106.6)	<0.0001*
Medication Costs	3596.3 [1373.2, 6860.0]	3979.3 [1916.4, 6709.8]	61.0 [0.0, 233.6]	<0.0001*
Medication Costs	4734.2 (4418.0)	4723.2 (3718.4)	1309.2 (3540.6)	<0.0001*
Number of Pain Encounters	0.0 [0.0, 1.0]	0.0 [0.0, 4.0]	0.0 [0.0, 9.0]	<0.0001*
Number of Pain Encounters	4.3 (12.3)	4.9 (11.8)	8.6 (25.3)	<0.0001*
Number of Pain Prescriptions	14.0 [6.0, 25.0]	9.0 [3.0, 17.0]	4.0 [0.0, 20.0]	<0.0001*
Number of Pain Prescriptions	17.0 (13.9)	11.4 (10.4)	11.7 (15.9)	<0.0001*